HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 35 filers reported holding HORIZON PHARMA INVT LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,225,000 | +3543.3% | 11,500,000 | +4081.8% | 0.01% | – |
| Q4 2019 | $363,000 | -95.5% | 275,000 | -96.6% | 0.00% | -100.0% |
| Q3 2018 | $8,047,000 | +5.1% | 8,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $7,656,000 | +87.6% | 8,000,000 | +79.7% | 0.00% | 0.0% |
| Q1 2018 | $4,081,000 | +192.5% | 4,451,000 | +196.5% | 0.00% | +100.0% |
| Q4 2017 | $1,395,000 | +93.2% | 1,501,000 | +87.6% | 0.00% | – |
| Q3 2017 | $722,000 | -78.0% | 800,000 | -79.0% | 0.00% | -100.0% |
| Q2 2017 | $3,281,000 | -6.0% | 3,807,000 | -0.8% | 0.00% | -33.3% |
| Q1 2017 | $3,490,000 | +15.6% | 3,836,000 | +20.8% | 0.00% | +50.0% |
| Q4 2016 | $3,019,000 | +41.9% | 3,175,000 | +44.3% | 0.00% | 0.0% |
| Q3 2016 | $2,127,000 | +6.7% | 2,200,000 | -0.1% | 0.00% | +100.0% |
| Q2 2016 | $1,994,000 | +202.1% | 2,202,000 | +184.1% | 0.00% | – |
| Q1 2016 | $660,000 | – | 775,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 99,100,000 | $94,914,000 | 3.33% |
| Lion Point Capital, LP | 16,000,000 | $15,312,000 | 1.38% |
| SYMPHONY ASSET MANAGEMENT LLC | 5,000,000 | $4,804,000 | 0.96% |
| LINDEN ADVISORS LP | 32,106,000 | $30,888,000 | 0.95% |
| OAKTREE CAPITAL MANAGEMENT LP | 46,262,000 | $44,449,000 | 0.62% |
| Nicholas Investment Partners, LP | 8,635,000 | $8,264,000 | 0.58% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 16,785,000 | $16,100,000 | 0.34% |
| CANYON CAPITAL ADVISORS LLC | 30,000,000 | $28,712,000 | 0.32% |
| SSI INVESTMENT MANAGEMENT LLC | 3,250,000 | $3,110,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,278,000 | $6,031,000 | 0.17% |